17.25
1.54%
-0.27
Pre-market:
16.01
-1.24
-7.19%
Xencor Inc Stock (XNCR) Latest News
Xencor (XNCR) Loses -25.22% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
BlackRock, Inc. Increases Stake in Xencor Inc. - GuruFocus.com
Ratios Reveal: Breaking Down Xencor Inc (XNCR)’s Financial Health - The Dwinnex
Xencor's SWOT analysis: biotech stock faces mixed outlook amid pipeline progress - MSN
Xencor Inc [XNCR] Stock sold by Insider Montgomery Alan Bruce for $0.36 million - Knox Daily
Some Confidence Is Lacking In Xencor, Inc. (NASDAQ:XNCR) As Shares Slide 27% - Simply Wall St
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Xencor (NASDAQ:XNCR investor five-year losses grow to 50% as the stock sheds US$96m this past week - Yahoo Finance
Xencor, Inc. (NASDAQ:XNCR) Short Interest Up 21.4% in January - Defense World
Xencor: Substantial Promise, Slow Progress (NASDAQ:XNCR) - Seeking Alpha
(XNCR) Investment Analysis - Stock Traders Daily
Xencor Insiders Sold US$891k Of Shares Suggesting Hesitancy - Simply Wall St
Xencor's SWOT analysis: biotech stock navigates pipeline progress amid market challenges - MSN
Xencor (NASDAQ:XNCR) Trading Down 3.9%Should You Sell? - MarketBeat
Down -21.69% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround - MSN
JPMorgan Chase & Co. Acquires 3,635 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR) - Yahoo Finance
Xencor (NASDAQ:XNCR) Stock Price Down 3.8%What's Next? - MarketBeat
Xencor Becomes Oversold (XNCR) - Nasdaq
Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know - MSN
Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks - Yahoo Finance
Xencor Highlights Progress in Drug Development Pipeline - TipRanks
Xencor (NASDAQ:XNCR) Trading Down 9.3%Here's Why - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
How To Trade (XNCR) - Stock Traders Daily
Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Principal Financial Group Inc. - Defense World
Is Xencor (NASDAQ:XNCR) Using Too Much Debt? - Simply Wall St
Geode Capital Management LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World
26,831 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Sanctuary Advisors LLC - Defense World
Sanctuary Advisors LLC Takes $540,000 Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Barclays PLC Raises Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World
Barclays PLC Increases Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
Intrahepatic Cholangiocarcinoma Pipeline Insights 2024: Therapies, Clinical Trials, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapeutics - The Globe and Mail
Fmr LLC Buys 12,729 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World
Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Jane Street Group LLC - MarketBeat
State Street Corp Reduces Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat
When (XNCR) Moves Investors should Listen - Stock Traders Daily
Xencor (NASDAQ:XNCR) Earns Overweight Rating from Analysts at Wells Fargo & Company - Defense World
Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Xencor's SWOT analysis: biotech stock balances promise and challenges - Investing.com
Xencor's SWOT analysis: biotech stock balances promise and challenges By Investing.com - Investing.com Canada
Wells Fargo Initiates Coverage of Xencor (XNCR) with Overweight Recommendation - MSN
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):